Discreet, evidence-based care for Illinois women — HSDD, perimenopause, menopausal hormone therapy, low-dose testosterone for women, and vaginal estrogen — delivered by clinicians licensed in Illinois.
OmniRx Health providers hold active Illinois Department of Financial and Professional Regulation licenses for statewide telehealth practice.
Hypoactive sexual desire disorder affects about 1 in 10 adult women. Treatable with FDA-approved Addyi or Vyleesi, low-dose testosterone, and addressing modifiable contributors like SSRIs and contraceptive choice.
Modern menopausal hormone therapy — typically transdermal estradiol with cyclic or continuous progesterone — for hot flashes, sleep disruption, libido changes, and mood symptoms.
Local vaginal estrogen, DHEA inserts (prasterone), and ospemifene for genitourinary symptoms with very low systemic absorption.
Off-label and supported by international guidelines for postmenopausal HSDD. Carefully titrated based on baseline labs, with quarterly monitoring.
Illinois telehealth laws comprehensively support virtual care delivery, with requirements that balance patient protection and provider flexibility.
Our pharmacy network spans Chicago, the suburbs, and downstate Illinois, ensuring prescription access whether you're in Lincoln Park or Little Egypt.
Visits, intake forms, and lab results are protected health information. Medication ships in plain, unmarked packaging anywhere in Illinois. If you choose cash-pay, no insurance EOB is sent to your household.